We are live on ! Find out more
WMSA

Weiss Multi-Strategy Advisers Portfolio holdings

AUM $4.16B
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
-0.3%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$2.3B
AUM Growth
+$850M
Cap. Flow
+$795M
Cap. Flow %
34.54%
Top 10 Hldgs %
16.37%
Holding
602
New
223
Increased
122
Reduced
83
Closed
146

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$40.2M
2
AIV
Aimco
AIV
+$38.4M
3
DEI icon
Douglas Emmett
DEI
+$32.6M
4
BDN
Brandywine Realty Trust
BDN
+$28M
5
KRC icon
Kilroy Realty
KRC
+$25.3M

Sector Composition

Rank Sector Weight
1 Real Estate 23.49%
2 Financials 11.65%
3 Energy 8.84%
4 Consumer Discretionary 7.75%
5 Industrials 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVLG icon
401
Covenant Logistics
CVLG
$1.18B
$385K 0.02%
+31,856
New +$321K
TXMD icon
402
TherapeuticsMD
TXMD
$23.8M
$378K 0.02%
1,181
+881
+294% +$301K
TNK icon
403
Teekay Tankers
TNK
$2.63B
$367K 0.02%
+12,500
New +$431K
ANTH
404
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$366K 0.02%
12,625
MU icon
405
CALL
Micron Technology
MU
$1.04T
$363K 0.02%
34,700
-17,000
-33% -$190K
XENE icon
406
Xenon Pharmaceuticals
XENE
$6.32B
$356K 0.02%
51,000
+6,000
+13% +$43.1K
ABT icon
407
Abbott
ABT
$180B
$354K 0.02%
8,467
-31,869
-79% -$1.26M
CRIS icon
408
Curis
CRIS
$9.53M
$343K 0.01%
107
LAB icon
409
Standard BioTools
LAB
$326M
$323K 0.01%
40,000
+30,000
+300% +$216K
HTWR
410
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$314K 0.01%
+10,000
New +$338K
ALDX icon
411
Aldeyra Therapeutics
ALDX
$91.7M
$298K 0.01%
71,172
-4,828
-6% -$23.2K
SPNC
412
DELISTED
Spectranetics Corp
SPNC
$290K 0.01%
+20,000
New +$277K
ROL icon
413
Rollins
ROL
$18.6B
$284K 0.01%
+23,549
New +$279K
BLCM
414
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$281K 0.01%
3,000
+450
+18% +$49K
ACAD icon
415
PUT
Acadia Pharmaceuticals
ACAD
$4.25B
$280K 0.01%
+10,000
New +$218K
NVDQ
416
DELISTED
Novadaq Technologies Inc.
NVDQ
$277K 0.01%
25,000
ESPR
417
DELISTED
Esperion Therapeutics
ESPR
$271K 0.01%
16,000
TTOO
418
DELISTED
T2 Biosystems, Inc
TTOO
$247K 0.01%
5
INFI
419
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$240K 0.01%
45,500
VA
420
DELISTED
Virgin America Inc.
VA
$239K 0.01%
+6,196
New +$193K
XTLY
421
DELISTED
Xactly Corporation
XTLY
$226K 0.01%
32,925
-1,037
-3% -$6.65K
GLNG icon
422
Golar LNG
GLNG
$4.95B
$222K 0.01%
12,362
+794
+7% +$13.6K
TSRO
423
PUT
DELISTED
TESARO, Inc.
TSRO
$220K 0.01%
+5,000
New +$201K
HTLD icon
424
Heartland Express
HTLD
$1.11B
$219K 0.01%
11,831
-38,169
-76% -$686K
BFX
425
DELISTED
BowFlex Inc.
BFX
$218K 0.01%
+11,274
New +$212K

Similar funds

Weiss Multi-Strategy Advisers's Q1 2016 Portfolio in Review

As of Q1 2016, Weiss Multi-Strategy Advisers held 602 positions worth $2.3B, up 59% from $1.45B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Weiss Multi-Strategy Advisers deployed $795M of net new capital in Q1 2016, opening 223 new positions and adding to 122 existing holdings. Its largest new stake was Prologis: 1,000,337 shares worth $44.2M.

By sector, the portfolio is most concentrated in Real Estate at 23% of assets, up from 21% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was Validus Hold Ltd, an estimated $11.9M trimmed.

  • Weiss Multi-Strategy Advisers's largest Q1 2016 buy was Prologis: 1,000,337 shares worth $44.2M.
  • Weiss Multi-Strategy Advisers added most to Brandywine Realty Trust in Q1 2016, an estimated $28M increase.
  • Weiss Multi-Strategy Advisers's biggest Q1 2016 reduction was Validus Hold Ltd, cutting an estimated $11.9M.
  • Weiss Multi-Strategy Advisers fully exited Macerich in Q1 2016, selling an estimated $23.4M.
  • Weiss Multi-Strategy Advisers's ten largest holdings make up 16% of its $2.3B portfolio in Q1 2016.
  • Weiss Multi-Strategy Advisers opened 223 new positions and closed 146 in Q1 2016.
  • Weiss Multi-Strategy Advisers's portfolio value rose 59% quarter-over-quarter to $2.3B.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2016, filed 16 May 2016.